Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Inventory Average (2022 - 2024)

Whitehawk Therapeutics (WHWK) has disclosed Inventory Average for 3 consecutive years, with $5.4 million as the latest value for Q4 2024.

  • On a quarterly basis, Inventory Average rose 7.34% to $5.4 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.4 million, a 7.34% increase, with the full-year FY2024 number at $5.9 million, up 41.63% from a year prior.
  • Inventory Average was $5.4 million for Q4 2024 at Whitehawk Therapeutics, down from $5.8 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $6.2 million in Q1 2024 to a low of $464500.0 in Q2 2022.
  • A 3-year average of $3.7 million and a median of $3.6 million in 2023 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: skyrocketed 681.49% in 2023, then grew 7.34% in 2024.
  • Whitehawk Therapeutics' Inventory Average stood at $1.3 million in 2022, then surged by 286.97% to $5.0 million in 2023, then grew by 7.34% to $5.4 million in 2024.
  • Per Business Quant, the three most recent readings for WHWK's Inventory Average are $5.4 million (Q4 2024), $5.8 million (Q3 2024), and $6.0 million (Q2 2024).